Liraglutide and dulaglutide, as GLP-1R agonists, can improve AD-related cognitive dysfunction by inhibiting tau protein hyperphosphorylation and NFTs formation through activation of the protein kinase B/glycogen synthase kinase 3 beta (Akt/GSK-3) signaling pathway (Shu et al., 2019
Therapeutic opportunities within the DNA damage response
To maximize the effectiveness of tirzepatide, adopt a healthy lifestyle that includes a balanced diet, regular exercise, adequate rest, and consistent follow-up with your healthcare provider
The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice
new growth at 8 to 16 weeks
GLP-1 drug therapy helps in multiple ways: Improves insulin production when blood sugar is high Reduces the release of glucagon, a hormone that increases blood sugar Slows down gastric emptying, making you feel full for longer Reduces appetite, leading to fewer calorie intakes These combined effects make GLP-1 agonists powerful tools for diabetes weight control